Preventive and therapeutic effects of co-administration of <i>Bacteroides thetaiotaomicron</i> and infliximab on dextran sodium sulfate-induced colitis in mice
These findings underscore the therapeutic potential of B. thetaiotaomicron in IBD, either alone or in combination with infliximab, and support further development of microbiota-based strategies for IBD prevention and treatment.
Authors
- Seyed Amirhesam Seyedi
- Shohreh Khatami (ORCID: https://orcid.org/0000-0001-9514-7571)
- Mehdi D. Davari (ORCID: https://orcid.org/0000-0003-0089-7156)
- Arian Kariman
- Sara Ahmadi Badi (ORCID: https://orcid.org/0000-0001-8679-1277)
- Seyed Davar Siadat (ORCID: https://orcid.org/0000-0002-6892-5603)
- Pejman Rohani (ORCID: https://orcid.org/0000-0002-4208-8130)
- Ahmad Berimipour
- Hamid Reza Moradi (ORCID: https://orcid.org/0000-0001-5854-085X)
- Shima Shojaie
- Mohammad Hassan Sohouli
- Hananeh Tavakoli Aval
Institutions
- University of North Texas (US)
- Pasteur Institute of Iran (IR)
- Shiraz University (IR)
- Children's Medical Center (IR)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-12-12
- DOI
- https://doi.org/10.5217/ir.2025.00061
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00